navierre

person with vial in front of computer monitor
By  Trevor Dermody 01:02 pm April 5, 2024
AI-enabled cardiovascular company Cardio Diagnostics Holdings announced it is partnering with care-navigation platform Navierre to make assessing risk and diagnosing heart diseases more accessible.  Cardio Diagnostics Holdings' AI solutions, Epi+GenCHD and PrecisionCHD, use blood samples to provide patients with personalized information regarding their risk for coronary heart disease based on...